Institutional Ownership Cytek Biosciences, Inc. (CTKB)
This table provides information about the institutional ownership of Cytek Biosciences, Inc. (CTKB). We have compiled data on the 154 institutions that hold shares in the stock, with a total of 73.8 Million shares, which have been reported (via 13F filing form) to have a value of $298 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
17,070,422
shares
|
$68.8 Million
0.0% of portfolio
|
Q2 2024
Reduced 2.04%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
7,765,138
shares
|
$31.3 Million
0.0% of portfolio
|
Q2 2025
Reduced 19.3%
|
|
Brown Capital Management LLC
Baltimore, MD |
Aug 13, 2025 Q2 2025 |
7,109,995
shares
|
$28.7 Million
0.72% of portfolio
|
Q2 2025
Reduced 4.74%
|
|
Hhlr Advisors, Ltd.
Grand Cayman, E9 |
Aug 14, 2025 Q2 2025 |
6,657,030
shares
|
$26.8 Million
0.93% of portfolio
|
Q2 2023
Reduced 13.58%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
4,173,763
shares
|
$16.8 Million
0.0% of portfolio
|
Q2 2025
Reduced 4.76%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
3,454,806
shares
|
$13.9 Million
0.0% of portfolio
|
Q2 2025
Added 21.06%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
2,729,593
shares
|
$11 Million
0.0% of portfolio
|
Q2 2025
Added 1.6%
|
|
New York State Common Retirement Fund
|
Aug 13, 2025 Q2 2025 |
2,088,390
shares
|
$8.42 Million
0.01% of portfolio
|
Q3 2024
Reduced 29.18%
|
|
Royce & Associates LP
|
Aug 11, 2025 Q2 2025 |
1,389,806
shares
|
$5.6 Million
0.05% of portfolio
|
Q2 2025
Added 145.63%
|
|
Aqr Capital Management LLC
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
1,238,393
shares
|
$4.99 Million
0.0% of portfolio
|
Q2 2025
Added 89.57%
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
1,150,121
shares
|
$4.63 Million
0.0% of portfolio
|
Q2 2025
Added 54.28%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
1,095,994
shares
|
$4.42 Million
0.0% of portfolio
|
Q2 2025
Reduced 4.83%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
1,063,139
shares
|
$4.28 Million
0.01% of portfolio
|
Q2 2025
Added 54.62%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,016,557
shares
|
$4.1 Million
0.0% of portfolio
|
Q2 2025
Reduced 12.21%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
924,772
shares
|
$3.73 Million
0.0% of portfolio
|
Q2 2025
Added 86.66%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
909,590
shares
|
$3.67 Million
0.0% of portfolio
|
Q2 2025
Reduced 17.68%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Aug 14, 2025 Q2 2025 |
888,339
shares
|
$3.58 Million
0.01% of portfolio
|
Q2 2025
Added 25.39%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
671,313
shares
|
$2.71 Million
0.0% of portfolio
|
Q1 2025
Reduced 29.16%
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
632,052
shares
|
$2.55 Million
0.0% of portfolio
|
Q2 2025
Added 3.36%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
617,085
shares
|
$2.49 Million
0.0% of portfolio
|
Q2 2025
Added 2.42%
|
|
Principal Financial Group Inc
Des Moines, IA |
Aug 08, 2025 Q2 2025 |
572,387
shares
|
$2.31 Million
0.0% of portfolio
|
Q2 2025
Added 9.92%
|
|
Numerai Gp LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
422,318
shares
|
$1.7 Million
0.21% of portfolio
|
Q2 2025
New holding
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Aug 14, 2025 Q2 2025 |
412,311
shares
|
$1.66 Million
0.0% of portfolio
|
Q2 2025
Added 48.66%
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
387,908
shares
|
$1.56 Million
0.0% of portfolio
|
Q2 2025
Added 153.76%
|
|
Algert Global LLC
San Francisco, CA |
Aug 13, 2025 Q2 2025 |
372,238
shares
|
$1.5 Million
0.03% of portfolio
|
Q2 2025
Reduced 9.52%
|